Paten

Paten

Teknologi yang dipatenkan oleh Kumpulan CryoCord seperti disenaraikan di bawah mewakili sumbangan utama yang telah diiktiraf secara rasmi dan dilindungi melalui pemberian paten di peringkat nasional dan antarabangsa.

No. Syarikat Negara Paten Kod Paten Tajuk Paten
1 Cytopeutics Amerika Syarikat US 10,278,993 B2 CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF ACUTE STROKE
2 Cytopeutics Amerika Syarikat US 10,828,332 B2 CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF VERNAL KERATOCONJUNCTIVITIS
3 Cytopeutics Amerika Syarikat US 11,052,119 B2 CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES
4 CryoCord Malaysia MY-196334-A A METHOD FOR SCREENING BIOLOGICAL SPECIMEN AND MESENCHYMAL STEM CELL OR MULTIPOTENT STROMAL CELLS TO ESTABLISH MASTER CELL LINE
5 CryoCord Malaysia MY-198403-A PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
6 CryoCord Malaysia MY-211187-A METHOD OF GENETICALLY MODIFYING STEM CELLS
7 Cytopeutics Malaysia MY-171193-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND ASSOCIATED METABOLIC DISORDERS AND FOR AMELIORATION OF INSULIN RESISTANCE IN PRE-DIABETES
8 Cytopeutics Malaysia MY-173966-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF ACUTE STROKE
9 Cytopeutics Malaysia MY-176109-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF CRITICAL LIMB ISCHEMIA
10 Cytopeutics Malaysia MY-171690-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF END-STAGE ISCHEMIC CARDIOMYOPATHY
11 Cytopeutics Malaysia MY-171311-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETIC MACULAR OEDEMA
12 Cytopeutics Malaysia MY-173386-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF VERNAL KERATOCONJUNCTIVITIS
13 Cytopeutics Malaysia MY-176088-A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF PSORIASIS AND AUTOIMMUNE DISEASES
14 Cytopeutics Malaysia MY-200544-A A METHOD OF EXPANDING AND GENERATING A POPULATION OF CYTOKINE-INDUCED KILLER CELLS FROM PERIPHERAL BLOOD
15 Cytopeutics Malaysia MY-206887-A A CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
Nota: Cytopeutics adalah anak syarikat CryoCord Group, yang memberi tumpuan utama kepada penyelidikan dan rawatan sel stem.

Teroka Lagi